News
What else does weight-loss drug Ozempic do? 5 unexpected health benefits - Emerging scientific research indicates that ...
Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...
Lilly’s oral diabetes pill shows potential for blood sugar control and weight loss in global trial
The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...
Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.
Eli Lilly said in February that it will invest at least $27 billion to build four new manufacturing sites in the U.S. as ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results